{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T09:08:03Z","timestamp":1793869683282,"version":"4.6.1"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T00:00:00Z","timestamp":1746144000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eClinicalMedicine"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.eclinm.2025.103256","type":"journal-article","created":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T11:20:16Z","timestamp":1748431216000},"page":"103256","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Measure selection for an electronic patient-reported outcome (ePRO) system for CAR T-cell therapy patients: a modified Delphi consensus study"],"prefix":"10.1016","volume":"84","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5656-1198","authenticated-orcid":false,"given":"Sarah E.","family":"Hughes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Foram","family":"Khatsuria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christel","family":"McMullan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen L.","family":"Shaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita","family":"Walker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Kinsella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Burns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9122-8251","authenticated-orcid":false,"given":"Olalekan L.","family":"Aiyegbusi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elin Haf","family":"Davies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Ansell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evelyn","family":"Chakera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Craddock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alastair","family":"Denniston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Lloyd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Ferguson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronjon","family":"Chakraverty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie","family":"Calvert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.eclinm.2025.103256_bib1","doi-asserted-by":"crossref","DOI":"10.1097\/HS9.0000000000000802","article-title":"Chimeric antigen receptor T-cell therapy in hematologic malignancies and patient-reported outcomes: a scoping review","volume":"6","author":"Efficace","year":"2022","journal-title":"Hemasphere"},{"issue":"1","key":"10.1016\/j.eclinm.2025.103256_bib2","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/nrclinonc.2017.148","article-title":"Chimeric antigen receptor T-cell therapy - assessment and management of toxicities","volume":"15","author":"Neelapu","year":"2018","journal-title":"Nat Rev Clin Oncol"},{"issue":"2","key":"10.1016\/j.eclinm.2025.103256_bib3","first-page":"42","article-title":"Adult survivorship: considerations following CAR T-cell therapy","volume":"23","author":"Buitrago","year":"2019","journal-title":"Clin J Oncol Nurs"},{"issue":"1","key":"10.1016\/j.eclinm.2025.103256_bib4","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/ejh.14100","article-title":"Long-term survivorship care after CAR-T cell therapy","volume":"112","author":"Puckrin","year":"2023","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.eclinm.2025.103256_bib5","series-title":"Qualification process for drug development tools guidance for industry and FDA staff","year":"2020"},{"key":"10.1016\/j.eclinm.2025.103256_bib6","series-title":"Core patient-reported outcomes in cancer clinical trials","year":"2021"},{"issue":"6","key":"10.1016\/j.eclinm.2025.103256_bib7","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1200\/JCO.2015.63.0830","article-title":"Symptom monitoring with patient-reported outcomes during routine cancer treatment: a randomized controlled trial","volume":"34","author":"Basch","year":"2016","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.eclinm.2025.103256_bib8","doi-asserted-by":"crossref","DOI":"10.1038\/s43856-022-00116-5","article-title":"Patient-reported outcomes and neurotoxicity markers in patients treated with bispecific LV20.19 CAR T cell therapy","volume":"2","author":"Knight","year":"2022","journal-title":"Commun Med"},{"issue":"2","key":"10.1016\/j.eclinm.2025.103256_bib9","doi-asserted-by":"crossref","first-page":"11","DOI":"10.46989\/001c.115793","article-title":"Outpatient CAR T-cell therapy as standard of care: current perspectives and considerations","volume":"6","author":"Gatwood","year":"2024","journal-title":"Clin Hematol Int"},{"issue":"5","key":"10.1016\/j.eclinm.2025.103256_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtct.2021.01.003","article-title":"Patient-reported outcomes for cancer patients with hematological malignancies undergoing chimeric antigen receptor T cell therapy: a systematic review","volume":"27","author":"Kamal","year":"2021","journal-title":"Transpl Cell Ther"},{"issue":"3","key":"10.1016\/j.eclinm.2025.103256_bib11","doi-asserted-by":"crossref","DOI":"10.1200\/EDBK_438512","article-title":"Integrating patient-reported outcomes into the care of people with advanced cancer\u2014a practical guide","volume":"44","author":"Lai-Kwon","year":"2024","journal-title":"Am Soc Clin Oncol Educ Book"},{"issue":"3","key":"10.1016\/j.eclinm.2025.103256_bib12","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2024-085392","article-title":"Protocol for a mixed-methods study to develop and feasibility test a digital system for the capture of patient-reported outcomes (PROs) in patients receiving chimeric antigen receptor T-cell (CAR-T) therapies (the PRO-CAR-T study)","volume":"14","author":"Hughes","year":"2024","journal-title":"BMJ Open"},{"issue":"10","key":"10.1016\/j.eclinm.2025.103256_bib13","doi-asserted-by":"crossref","first-page":"e476","DOI":"10.1016\/S1470-2045(24)00256-0","article-title":"Development of a conceptual framework for an electronic patient-reported outcome (ePRO) system measuring symptoms and impacts of CAR T-cell therapies in patients with haematological malignancies","volume":"25","author":"Khatsuria","year":"2024","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.eclinm.2025.103256_bib14","series-title":"Patient-focused drug development: selecting, developing, or modifying fit-for-purpose clinical outcome assessments","year":"2022"},{"issue":"1","key":"10.1016\/j.eclinm.2025.103256_bib15","article-title":"How do patients interpret and respond to a single-item global indicator of cancer treatment tolerability?","volume":"31","author":"Peipert","year":"2022","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.eclinm.2025.103256_bib16","series-title":"Position statement on use of the EQ-5D-5L value set for England (updated October 2019) | Technology appraisal guidance | NICE guidance | Our programmes | what we do | about","year":"2019"},{"issue":"1","key":"10.1016\/j.eclinm.2025.103256_bib17","doi-asserted-by":"crossref","DOI":"10.1186\/s13643-023-02337-8","article-title":"Patient-reported outcome (PRO) instruments used in patients undergoing adoptive cell therapy (ACT) for the treatment of cancer: a systematic review","volume":"12","author":"Taylor","year":"2023","journal-title":"Syst Rev"},{"issue":"1","key":"10.1016\/j.eclinm.2025.103256_bib18","doi-asserted-by":"crossref","DOI":"10.1186\/s41687-023-00634-3","article-title":"Development and usability testing of an electronic patient-reported outcome (ePRO) solution for patients with inflammatory diseases in an Advanced Therapy Medicinal Product (ATMP) basket trial","volume":"7","author":"McMullan","year":"2023","journal-title":"J Patient Rep Outcomes"},{"issue":"12","key":"10.1016\/j.eclinm.2025.103256_bib19","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/S2213-2600(23)00370-3","article-title":"Core outcome measurement instruments for use in clinical and research settings for adults with post-COVID-19 condition: an international Delphi consensus study","volume":"11","author":"Gorst","year":"2023","journal-title":"Lancet Respir Med"},{"issue":"S3","key":"10.1016\/j.eclinm.2025.103256_bib20","doi-asserted-by":"crossref","DOI":"10.1186\/s13063-017-1978-4","article-title":"The COMET Handbook: version 1.0","volume":"18","author":"Williamson","year":"2017","journal-title":"Trials"},{"key":"10.1016\/j.eclinm.2025.103256_bib21","series-title":"COSMIN methodology for assessing the content validity of PROMs User manual Version 1.0: COSMIN","author":"Terwee","year":"2017"},{"issue":"3","key":"10.1016\/j.eclinm.2025.103256_bib22","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1136\/ebnurs-2020-103303","article-title":"What are Delphi studies?","volume":"23","author":"Barrett","year":"2020","journal-title":"Evid Base Nurs"},{"issue":"2","key":"10.1016\/j.eclinm.2025.103256_bib23","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/his.14650","article-title":"Developing consensus in Histopathology: the role of the Delphi method","volume":"81","author":"Taze","year":"2022","journal-title":"Histopathology"},{"issue":"12","key":"10.1016\/j.eclinm.2025.103256_bib24","doi-asserted-by":"crossref","first-page":"2573","DOI":"10.1038\/s41366-018-0313-9","article-title":"A Delphi study to build consensus on the definition and use of big data in obesity research","volume":"43","author":"Vogel","year":"2019","journal-title":"Int J Obes"},{"issue":"2","key":"10.1016\/j.eclinm.2025.103256_bib25","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1111\/hex.12462","article-title":"Agreeing the content of a patient-reported outcome measure for primary care: a Delphi consensus study","volume":"20","author":"Murphy","year":"2016","journal-title":"Health Expect"},{"key":"10.1016\/j.eclinm.2025.103256_bib26","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2022-070230","article-title":"Development and validation of the symptom burden questionnaire for long covid (SBQ-LC): rasch analysis","author":"Hughes","year":"2022","journal-title":"BMJ"},{"issue":"4","key":"10.1016\/j.eclinm.2025.103256_bib27","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/sj.bmt.1700672","article-title":"Quality of life measurement in bone marrow transplantation: development of the Functional Assessment of Cancer Therapy-Bone Marrow Transplant (FACT-BMT) scale","volume":"19","author":"McQuellon","year":"1997","journal-title":"Bone Marrow Transplant"},{"issue":"4","key":"10.1016\/j.eclinm.2025.103256_bib28","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1007\/s11136-004-2147-2","article-title":"Assessing quality of life in adult cancer survivors (QLACS)","volume":"14","author":"Avis","year":"2005","journal-title":"Qual Life Res"},{"issue":"4","key":"10.1016\/j.eclinm.2025.103256_bib29","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1111\/j.1365-2753.2008.01057.x","article-title":"Brief assessment of adult cancer patients' perceived needs: development and validation of the 34-item Supportive Care Needs Survey (SCNS-SF34)","volume":"15","author":"Boyes","year":"2009","journal-title":"J Eval Clin Pract"},{"issue":"6","key":"10.1016\/j.eclinm.2025.103256_bib30","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/BF00704432","article-title":"Measurement of quality of life in bone marrow transplantation survivors","volume":"1","author":"Grant","year":"1992","journal-title":"Qual Life Res"},{"issue":"1","key":"10.1016\/j.eclinm.2025.103256_bib31","doi-asserted-by":"crossref","DOI":"10.1186\/s12885-015-1261-6","article-title":"Improving the assessment of quality of life in the clinical care of myeloma patients: the development and validation of the Myeloma Patient Outcome Scale (MyPOS)","volume":"15","author":"Osborne","year":"2015","journal-title":"BMC Cancer"},{"issue":"4","key":"10.1016\/j.eclinm.2025.103256_bib32","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1111\/bjh.18677","article-title":"Development and validation of a patient-reported outcome measure to assess symptom burden after chimeric antigen receptor T-cell therapy","volume":"201","author":"Wang","year":"2023","journal-title":"Br J Haematol"},{"issue":"6","key":"10.1016\/j.eclinm.2025.103256_bib33","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1111\/medu.13241","article-title":"Professional identity in clinician-scientists: brokers between care and science","volume":"51","author":"Kluijtmans","year":"2017","journal-title":"Med Educ"},{"issue":"3","key":"10.1016\/j.eclinm.2025.103256_bib34","doi-asserted-by":"crossref","first-page":"e407","DOI":"10.1200\/OP.22.00501","article-title":"Development of a core set of patient- and caregiver-reported signs and symptoms to facilitate early recognition of acute chimeric antigen receptor T-cell therapy toxicities","volume":"19","author":"Spanjaart","year":"2023","journal-title":"JCO Oncology Practice"},{"issue":"3","key":"10.1016\/j.eclinm.2025.103256_bib35","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1038\/s41591-024-02827-9","article-title":"Recommendations to address respondent burden associated with patient-reported outcome assessment","volume":"30","author":"Aiyegbusi","year":"2024","journal-title":"Nat Med"},{"issue":"4","key":"10.1016\/j.eclinm.2025.103256_bib36","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1182\/bloodadvances.2019000952","article-title":"Comparing CAR T-cell toxicity grading systems: application of the ASTCT grading system and implications for management","volume":"4","author":"Pennisi","year":"2020","journal-title":"Blood Adv"},{"issue":"8","key":"10.1016\/j.eclinm.2025.103256_bib37","first-page":"3669","article-title":"The association between clinician-based common terminology criteria for adverse events (CTCAE) and patient-reported outcomes (PRO): a systematic review","volume":"24","author":"Atkinson","year":"2016","journal-title":"Support Care Cancer"},{"issue":"23","key":"10.1016\/j.eclinm.2025.103256_bib38","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1093\/jnci\/djp386","article-title":"Adverse symptom event reporting by patients vs clinicians: relationships with clinical outcomes","volume":"101","author":"Basch","year":"2009","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.eclinm.2025.103256_bib50","author":"UK Stem Cell Strategic"},{"issue":"1","key":"10.1016\/j.eclinm.2025.103256_bib39","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/0040-1625(79)90007-6","article-title":"Stability and agreement criteria for the termination of Delphi studies","volume":"13","author":"Dajani","year":"1979","journal-title":"Technol Forecast Soc Change"},{"key":"10.1016\/j.eclinm.2025.103256_bib40","author":"Lindemann"},{"issue":"2","key":"10.1016\/j.eclinm.2025.103256_bib41","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1111\/j.1753-6405.2012.00854.x","article-title":"In the 21st Century, what is an acceptable response rate?","volume":"36","author":"Morton","year":"2012","journal-title":"Aust N Z J Publ Health"},{"key":"10.1016\/j.eclinm.2025.103256_bib42","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.techfore.2019.07.002","article-title":"Improving the practical application of the Delphi method in group-based judgment: a six-step prescription for a well-founded and defensible process","volume":"147","author":"Belton","year":"2019","journal-title":"Technol Forecast Soc Change"},{"issue":"7","key":"10.1016\/j.eclinm.2025.103256_bib43","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000032829","article-title":"Use of Delphi in health sciences research: a narrative review","volume":"102","author":"Shang","year":"2023","journal-title":"Medicine"},{"issue":"1","key":"10.1016\/j.eclinm.2025.103256_bib44","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2288-5-37","article-title":"Stability of response characteristics of a Delphi panel: application of bootstrap data expansion","volume":"5","author":"Akins","year":"2005","journal-title":"BMC Med Res Methodol"},{"issue":"1","key":"10.1016\/j.eclinm.2025.103256_bib45","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1080\/13557858.2016.1182126","article-title":"The under-representation of minority ethnic groups in UK medical research","volume":"22","author":"Smart","year":"2016","journal-title":"Ethn Health"},{"issue":"7","key":"10.1016\/j.eclinm.2025.103256_bib46","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.jtct.2022.04.008","article-title":"Socioeconomic and racial disparity in chimeric antigen receptor T cell therapy access","volume":"28","author":"Ahmed","year":"2022","journal-title":"Transpl Cell Ther"},{"issue":"7","key":"10.1016\/j.eclinm.2025.103256_bib47","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.jtct.2024.04.017","article-title":"Chimeric antigen receptor T-cell access in patients with relapsed\/refractory large B-cell lymphoma: association of access with social determinants of health and travel time to treatment centers","volume":"30","author":"Ahmed","year":"2024","journal-title":"Transpl Cell Ther"},{"issue":"6","key":"10.1016\/j.eclinm.2025.103256_bib48","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1038\/s41591-022-01781-8","article-title":"Patient reported outcome assessment must be inclusive and equitable","volume":"28","author":"Calvert","year":"2022","journal-title":"Nat Med"},{"issue":"12","key":"10.1016\/j.eclinm.2025.103256_bib49","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2013.277222","article-title":"Patient-reported outcome alerts","volume":"310","author":"Kyte","year":"2013","journal-title":"JAMA"}],"container-title":["eClinicalMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589537025001889?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589537025001889?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T20:49:58Z","timestamp":1760215798000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589537025001889"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":50,"alternative-id":["S2589537025001889"],"URL":"https:\/\/doi.org\/10.1016\/j.eclinm.2025.103256","relation":{},"ISSN":["2589-5370"],"issn-type":[{"value":"2589-5370","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Measure selection for an electronic patient-reported outcome (ePRO) system for CAR T-cell therapy patients: a modified Delphi consensus study","name":"articletitle","label":"Article Title"},{"value":"eClinicalMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eclinm.2025.103256","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"103256"}}